Elephant Study Sheds Light on Lower Cancer Prevalence With Genomic Link to Human Disease | GenomeWeb

NEW YORK (GenomeWeb) – Multiple copies of the tumor suppressor gene TP53 appear to play a role in lower rates of cancer development in elephants, according to a new study led by Joshua Schiffman of the University of Utah School of Medicine.

The results, published today in the Journal  of the American Medical Association, may also have potential to provide a better understanding of the suppression (or promotion) of cancer in humans, according to Schiffman and his colleagues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.